Last updated on September 2017

Tazemetostat Rollover Study (TRuST): An Open-Label Rollover Study

Brief description of study

This study will provide continuing availability to tazemetostat as a single agent to subjects who have completed their participation in an antecedent tazemetostat study (either with monotherapy or combination therapy). In addition, long-term safety and overall survival will be collected.

Clinical Study Identifier: NCT02875548


Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Harry Miao, MD, PhD

Tucson, AZ United States
  Connect »

Harry Miao, MD, PhD

Villejuif Cedex, France
  Connect »